Overview

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Status:
Completed

Trial end date:
2013-04-01

Target enrollment:

Participant gender:

Summary

The proposed studies will examine the extent of pharmacokinetic and pharmacodynamic interactions between alcohol and various antiretroviral therapies in those with HIV/AIDS, HIV/HCV co-infection, mild HCV and healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

Efavirenz
Ethanol
Ritonavir